Innova Captab Ltd Q4 FY25 Results & Concall Highlights: Revenue, Margins & Order Book
Published 6 Aug 2026 | Pharmaceuticals & Biotechnology | Market Cap: ₹5.4K Cr
Innova Captab aims for a long-term CAGR of 25% revenue growth over the next 3 years. Innova Captab aims for a 25% CAGR revenue growth over the next 3 years.
From Innova Captab Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.
Price
₹1,088
Market Cap
₹5.4K Cr
P/E Ratio
38.5
How does Innova Captab Ltd rank in Pharmaceuticals & Biotechnology?
Compare Innova Captab Ltd against every Pharmaceuticals & Biotechnology company this quarter on revenue, margins and earnings-call signals.
Innova Captab Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹448 Cr, net profit ₹38 Cr.
Full financials →📊 Revenue & Sales Performance
- →Innova Captab aims for a long-term CAGR of 25% revenue growth over the next 3 years.
- →Jammu plant is expected to contribute around INR 400 crores in revenue for FY '26, with initial revenue of INR 36 crores in Q4 FY '25.
- →CDMO business volume growth is estimated around 7%-8% for the full year, slightly better than reported revenue growth of 6%-7%.
- →Sharon business aims to revive and grow positively post-CIRP, focusing on onboarding new customers and products, targeting regulated markets like Europe and Canada.
- →Domestic Branded Generics expect mid-teen growth rates (~12-13%), driven by volume growth, new products, and market penetration.
- →New products and dosage forms from the Jammu plant and R&D facility at Panchkula will accelerate growth.
- →EBITDA and profit margins are expected to improve with increased operations, operating leverage, GST benefits, and product mix improvements.
📈 Profitability & Margins
- →Innova Captab aims for a 25% CAGR revenue growth over the next 3 years.
- →Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) margin is expected to improve due to operating leverage, GST benefits, and operational efficiencies.
- →EBITDA neutral level at INR50-55 crores sales in Jammu plant indicates planned profitability growth.
- →PAT margins improved by 160 basis points to 10.3% in FY '25, with expectations to sustain or improve.
- →The new Jammu plant is poised to contribute INR400 crores revenue in FY '26, enhancing profits.
- →Revival and product expansion in Sharon business expected to drive growth in regulated markets.
- →Overall profit growth is supported by volume expansion, product mix improvement, and efficient resource utilization.
🏗️ Capital Expenditure Plans
- →Innova Captab has commissioned a new facility in Kathua, Jammu, which started commercial operations in January 2025.
- →The company expects the Jammu plant to generate around INR 400 crores in revenue in FY '26.
- →Upcoming R&D facility in Panchkula, Haryana focused on developing generic and complex generic products, including immediate release, super bioavailability capsules, and nano size formulations targeting regulated markets.
- →The Jammu plant includes expansion into acute products, beta-lactam, penem, LVP, respules, and waterfall injection formulations, reflecting strategic product portfolio diversification.
- →Working capital investments have increased to support rising operations and the startup of the Jammu plant, expected to normalize over time.
- →Capital expenditure includes maintenance capex consistent with existing depreciation rates, along with new facility investments to support growth and product innovation.
💰 Fundraising & Capital Structure
📋 Order Book & Pipeline
Key Metrics
Frequently Asked Questions
What were Innova Captab Ltd Q4 FY25 results?
Innova Captab aims for a long-term CAGR of 25% revenue growth over the next 3 years. Innova Captab aims for a 25% CAGR revenue growth over the next 3 years.
What is Innova Captab Ltd share price analysis?
Innova Captab Ltd currently shows a neutral. The stock trades at a P/E of 38.5 with a market cap of ₹5,408 Cr. Investors should review the full earnings analysis for detailed insights.
Is Innova Captab Ltd planning capital expenditure?
Innova Captab has commissioned a new facility in Kathua, Jammu, which started commercial operations in January 2025.
Keep Innova Captab Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
